15 November 2020

New Publication on Navigating Cross-Border Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield

Marcelo Corrales Compagnucci, Timo Minssen, Claudia Seitz, Mateo Aboy,have published a new paper in the European Pharmaceutical Law Review (EPLR) on the Schrems II judgment which invalidated the EU-US Privacy Shield Framework.
Key takeaways:
- Unfortunately, the Schrems II decision is far from illuminating and the ruling has resulted in significant uncertainty for organizations involved in EU-US cross-border transfers such as pharmaceutical companies, contract research organizations (CROs), and their technology providers engaged in global clinical trials.
- In this piece, we provide some ideas and solutions to mitigate those risks and uncertainties.
The paper is available at: